Lars Lund

2.9k total citations · 1 hit paper
180 papers, 1.8k citations indexed

About

Lars Lund is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Urology. According to data from OpenAlex, Lars Lund has authored 180 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Pulmonary and Respiratory Medicine, 63 papers in Surgery and 28 papers in Urology. Recurrent topics in Lars Lund's work include Renal cell carcinoma treatment (27 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Urinary Bladder and Prostate Research (21 papers). Lars Lund is often cited by papers focused on Renal cell carcinoma treatment (27 papers), Prostate Cancer Diagnosis and Treatment (25 papers) and Urinary Bladder and Prostate Research (21 papers). Lars Lund collaborates with scholars based in Denmark, United States and Sweden. Lars Lund's co-authors include Søren P. Sheikh, Charlotte Harken Jensen, Jens Ahm Sørensen, Ditte Caroline Andersen, Nessn Azawi, Navid Mohamadpour Toyserkani, Per Damkier, Mads Hvid Poulsen, Klaus Nielsen and Jes S. Lindholt and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Physiology.

In The Last Decade

Lars Lund

165 papers receiving 1.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

European Association of Urology Guidelines on Renal Cell Carcinoma: The 2025 Update

2025 18 citations Lars Lund et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Lars Lund Denmark	22	591	577	322	302	298	180	1.8k
Luigi Cormio Italy	26	952 1.6×	888 1.5×	425 1.3×	263 0.9×	348 1.2×	169	2.2k
Gholamreza Pourmand Iran	25	460 0.8×	591 1.0×	291 0.9×	296 1.0×	314 1.1×	134	2.0k
Massimiliano Creta Italy	24	554 0.9×	671 1.2×	771 2.4×	363 1.2×	156 0.5×	150	2.2k
Athanasios Papatsoris Greece	32	1.6k 2.8×	801 1.4×	756 2.3×	137 0.5×	435 1.5×	239	3.3k
Nabil K. Bissada United States	25	843 1.4×	1.1k 1.9×	644 2.0×	136 0.5×	438 1.5×	177	2.4k
Athanasios Dellis Greece	20	749 1.3×	339 0.6×	484 1.5×	113 0.4×	193 0.6×	99	1.3k
Eu Chang Hwang South Korea	26	1.3k 2.2×	901 1.6×	475 1.5×	101 0.3×	598 2.0×	229	2.8k
Juan Ignacio Martínez‐Salamanca Spain	28	586 1.0×	1.4k 2.4×	771 2.4×	975 3.2×	182 0.6×	180	2.5k
Michael J. Naslund United States	25	1.1k 1.8×	340 0.6×	969 3.0×	103 0.3×	262 0.9×	78	2.1k
Mario Sofer Israel	25	1.4k 2.4×	459 0.8×	523 1.6×	143 0.5×	150 0.5×	109	2.2k

Countries citing papers authored by Lars Lund

Since Specialization

Citations

This map shows the geographic impact of Lars Lund's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Lund with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Lund more than expected).

Fields of papers citing papers by Lars Lund

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Lund. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Lund. The network helps show where Lars Lund may publish in the future.

Co-authorship network of co-authors of Lars Lund

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Lund. A scholar is included among the top collaborators of Lars Lund based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Lund. Lars Lund is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Nielsen, Jakob V., Mark Burton, Mads Gustaf Jørgensen, et al.. (2025). Single-cell transcriptomics of clinical grade adipose-derived regenerative cells reveals consistency between donors independent of gender and BMI. Stem Cell Research & Therapy. 16(1). 109–109. 1 indexed citations

Antonsen, Kristian, Anna Thit Johnsen, Laurids Østergaard Poulsen, et al.. (2025). Assessing the effect of On-site supportive communication training (On-site SCT) on doctor burnout: a randomized controlled trial. BMC Medical Education. 25(1). 112–112. 2 indexed citations

Yderstræde, Knud Bonnet, et al.. (2025). Low-intensity extracorporeal shockwave therapy in patients with diabetic kidney disease: a matched cohort study. International Urology and Nephrology. 57(7). 2245–2253.

Schwartz, Uwe, et al.. (2024). Identification of natriuretic peptide receptor A-related gene expression signatures in podocytes in vivo reveals baseline control of protective pathways. American Journal of Physiology-Renal Physiology. 327(5). F806–F821.

Azawi, Nessn, Jane Christensen, Niels Viggo Jensen, et al.. (2024). Cytoreductive Nephrectomy in Select Primary Metastatic Renal Cell Carcinoma Patients: A Comprehensive Nationwide Outcome Analysis. Cancers. 16(6). 1132–1132. 1 indexed citations

Poulsen, Mads Hvid, et al.. (2023). Health‐related quality of life the first year after a prostate cancer diagnosis a systematic review. International Journal of Urological Nursing. 17(1). 15–28. 4 indexed citations

Høyer, S., et al.. (2023). Placebo-Controlled Study of Effects of Low-Energy Shockwave Therapy (LE-ESWT) on Erectile Tissue in a Diabetic Animal Model. Research and Reports in Urology. Volume 15. 123–129. 3 indexed citations

Yderstræde, Knud Bonnet, et al.. (2023). Low-Intensity Extracorporeal Shockwave Therapy (LI-ESWT) in Renal Diseases: A Review of Animal and Human Studies. International Journal of Nephrology and Renovascular Disease. Volume 16. 31–42. 3 indexed citations

Nørgaard, Birgitte, et al.. (2023). Patients' experiences of completing patient‐reported outcomes in clinical trials: An interview study. International Journal of Urological Nursing. 17(3). 180–187. 3 indexed citations

10.

Krhút, Jan, et al.. (2022). Clinical Utility of β3-Adrenoreceptor Agonists for the Treatment of Overactive Bladder: A Review of the Evidence and Current Recommendations. Research and Reports in Urology. Volume 14. 167–175. 2 indexed citations

11.

Rasmussen, Benjamin Schnack, et al.. (2022). Safety, efficacy, and mid-term oncological outcomes of computed tomography-guided cryoablation of T1 renal cancer. Acta Radiologica. 64(2). 814–820. 7 indexed citations

12.

Beck, Hans Christian, Eva Bang Harvald, Charlotte Harken Jensen, et al.. (2022). Adipose-Derived Stem Cells from Type 2 Diabetic Rats Retain Positive Effects in a Rat Model of Erectile Dysfunction. International Journal of Molecular Sciences. 23(3). 1692–1692. 11 indexed citations

13.

Nilsson, Line, Rikke Nørregaard, Rolf M. Nüsing, et al.. (2022). Increased COX‐2 after ureter obstruction attenuates fibrosis and is associated with EP₂ receptor upregulation in mouse and human kidney. Acta Physiologica. 235(4). e13828–e13828. 5 indexed citations

14.

Yderstræde, Knud Bonnet, et al.. (2021). Low-Intensity Shockwave Therapy (LI-ESWT) in Diabetic Kidney Disease: Results from an Open-Label Interventional Clinical Trial. International Journal of Nephrology and Renovascular Disease. Volume 14. 255–266. 5 indexed citations

15.

Hansen, Pernille, et al.. (2020). Natriuretic peptides relax human intrarenal arteries through natriuretic peptide receptor type‐A recapitulated by soluble guanylyl cyclase agonists. Acta Physiologica. 231(3). 18 indexed citations

16.

Thomsen, Frederik Birkebæk, Torben Brøchner Pedersen, Kasper Drimer Berg, Peter E. Clark, & Lars Lund. (2020). Comparison of venous thromboembolic complications following urological surgery between patients with or without cancer. SHILAP Revista de lepidopterología. 46(4). 277–281. 2 indexed citations

17.

Azawi, Nessn, et al.. (2020). Informing patients about the negative effect of nephrectomy on sexual function. SHILAP Revista de lepidopterología. 46(1). 18–25. 5 indexed citations

18.

Borrelli, Pablo, Mads Hvid Poulsen, Oke Gerke, et al.. (2019). Artificial intelligence‐based versus manual assessment of prostate cancer in the prostate gland: a method comparison study. Clinical Physiology and Functional Imaging. 39(6). 399–406. 23 indexed citations

19.

Lund, Lars, Harry Nísen, Petrus Järvinen, et al.. (2018). Use of venous-thrombotic-embolic prophylaxis in patients undergoing surgery for renal tumors: a questionnaire survey in the Nordic countries (The NORENCA -2 study). Research and Reports in Urology. Volume 10. 181–187. 1 indexed citations

20.

Andersen, Steven L., et al.. (2014). Treatment of Erectile Dysfunction with Extracorporeal Shockwave Therapy (ESWT): A Prospective, Randomised, Double-Blind, Placebo-Controlled Study. The Journal of Sexual Medicine. 11. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact